Transregional Collaborative Research Centre 152

Breadcrumb Navigation


Curriculum Vitae

Advanced Professional Positions

  • 2008 – present,  Full professor (W3) and head of the Rudolf-Boehm-Institute, Medical Faculty, University of Leipzig
  • 2004 – 2008 Professor (C3) “Pharmacology and Cellular Signal Transduction”, Charité - Universitätsmedizin Berlin
  • 2000 – 2004 Group leader and research assistant (C1), Institute of Pharmacology, Freie Universität Berlin and Charité - Universitätsmedizin Berlin, Advisor: Günter Schultz

Professional Experience and Postdoctoral Training

  • 1995 – 2000 Research fellow and first year resident, Institute of Pharmacology, Freie Universität Berlin, Germany, Advisors: Günter Schultz and Thomas Gudermann

Academic Education

  • 2003 Habilitation (Pharmacology and Toxicology), Freie Universität Berlin, Mentor: Günter Schultz
  • 2002 Specialist in Pharmacology and Toxicology, Facharztanerkennung der Ärztekammer Berlin
  • 1996 Dr. med., Ludwig-Maximilians-Universität München, Mentor: Rupert Gerzer
  • 1994 Medical Degree, Ludwig-Maximilians-Universität München

Honours, Awards, Scholarships and Other Qualifications

  • 2004 Research Award of the Carl-Zeiss-Stiftung
  • 2004 Professorship (C3) offered at the Ruprecht-Karls-Universität Heidelberg
  • 2003 Buchheim Award of the German Pharmacological Society (DGPT)
  • 1999 – 2002 Research Awards (2 first, 1 second) of the Medical Faculty, FU Berlin

Professional Activities, Memberships

  • since 2000 Member of the Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie
  • 2001-2007 Member of the American Society for Biochemistry and Molecular Biology
  • since 2008 Member of the German Purine Club


  • Straub I, Mohr F, Stab J, Konrad M, Philipp SE, Oberwinkler J, Schaefer M. Citrus fruit and fabacea secondary metabolites potently and selectively block TRPM3. Br J Pharmacol 168:1835-1850, 2013.
  • Nörenberg W, Sobottka H, Hempel C, Plötz T, Fischer W, Schmalzing G, Schaefer M. Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors. Br J Pharmacol 167:48-66, 2012.
  • Urban N, Hill K, Wang L, Kuebler WM, Schaefer M. Novel pharmacological TRPC inhibitors block hypoxia-induced vasoconstriction. Cell Calcium 51:194-206, 2012.
  • Nörenberg W, Hempel C, Urban N, Sobottka H, Illes P, Schaefer M. Clemastine potentiates the human P2X7 receptor by sensitizing it to lower ATP concentrations. J Biol Chem 286:11067-11081, 2011.
  • Hill K, Schaefer M. TRPA1 is differentially modulated by the amphipathic molecules trinitrophenol and chlorpromazine. J Biol Chem 282:7145-7153, 2007.